Hexachlorophene-induced brain edema in rat observed by proton magnetic resonance

Kinoshita, Yoshimasa; Matsumura, Hirohiko; Igisu, Hideki; Yokota, Akira

doi:10.1016/s0006-8993(00)02523-3

Cited by 11 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hexachlorophene has been shown to be neurotoxic in rats by inhibiting brain succinate dehydrogenase (SDH) activity, thus inducing spongiosis and brain edema (Kinosita et al, 2000). Hexachlorophene has not been tested before in models of neurodegenerative disorders.…”

Section: Discussionmentioning

confidence: 99%

Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease

Eleuteri

Giovanni

Rockenstein

et al. 2015

Neurobiology of Disease

View full text Add to dashboard Cite

Aβ accumulation plays a central role in the pathogenesis of Alzheimer's disease (AD). Recent studies suggest that process of Aβ nucleated polymerization is essential for Aβ fibril formation, pathology spreading and toxicity. Therefore, targeting this process represent an effective therapeutic strategy to slow or block disease progression. To discover compounds that might interfere with the Aβ seeding capacity, toxicity and pathology spreading, we screened a focused library of FDA-approved drugs in vitro using a seeding polymerization assay and identified small molecule inhibitors that specifically interfered with Aβ seeding-mediated fibril growth and toxicity. Mitoxantrone, bithionol and hexachlorophene were found to be the strongest inhibitors of fibril growth and protected primary cortical neuronal cultures against Aβ-induced toxicity. Next, we assessed the effects of these three inhibitors in vivo in the mThy1-APPtg mouse model of AD (8-month-old mice). We found that mitoxantrone and bithionol, but not hexachlorophene, stabilized diffuse amyloid plaques, reduced the levels of Aβ42 oligomers and ameliorated synapse loss, neuronal damage and astrogliosis. Together, our findings suggest that targeting fibril growth and Aβ seeding capacity constitutes a viable and effective strategy for protecting against neurodegeneration and disease progression in AD.

show abstract

Section: Discussionmentioning

confidence: 99%